- Overview
- Therapies
- Applied
Products - References
Reference literature for plasmapheresis methods.
- Hirata et al.
- Plasma separator Plasmaflo OP.
- Ther Apher Dial. 7:64-8, 2003
- Okada et al.
- New Treatment of Myonephropathic Metabolic Syndrome: Concomitant Plasma Exchange and Continuous Venovenous Hemofiltration.
- Jpn J Apheresis. 15:137-138, 1996.
- Hirata et al.
- Plasma separator Plasmaflo OP.
- Ther Apher Dial. 7:64-8, 2003.
- Julius et al.
- Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
- J Clin Apher. 22:215-23, 2007.
- Julius et al.
- Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
- Int J Artif Organs. 25:1180-8, 2002.
- Klingel et al.
- From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
- Ther Apher Dial. 7:350-8, 2003.
- Klingel et al.
- Lipidfiltration - safe and effective methodology to perform lipid-apheresis.
- Transfusion and Apheresis Science. 30:245-254, 2004.
- Taniguchi et al.
- Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C.
- Transplantation. 81:1747-9, 2006.
- Julius et al.
- Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
- J Clin Apher. 22:215-23, 2007.
- Fujiwara et al.
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load.
- Hepatol Res. 37:701-10, 2007.
- Yu et al.
- A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
- J Clin Rheumatol. 13:193-8, 2007.
- Julius et al.
- Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
- J Clin Apher. 22:215-23, 2007.
- Kaneko et al.
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C.
- Hepatol Res. 40:1072-1081, 2010.
- Fernández-Fuertes et al.
- Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
- Ther Apher Dial. 14:484-5, 2010.
- Liu et al.
- Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
- J Clin Apher. 26:174-80, 2011.
- Julius et al.
- Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
- Int J Artif Organs. 25:1180-8, 2002.
- Klingel et al.
- From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
- Ther Apher Dial. 7:350-8, 2003.
- Klingel et al.
- Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.
- Ther Apher Dial. 7:444-55, 2003.
- Klingel et al.
- Lipidfiltration - safe and effective methodology to perform lipid-apheresis.
- Transfusion and Apheresis Science. 30:245-254, 2004.
- Taniguchi et al.
- Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C.
- Transplantation. 81:1747-9, 2006.
- Fujiwara et al.
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load.
- Hepatol Res. 37:701-10, 2007.
- Yu et al.
- A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
- J Clin Rheumatol. 13:193-8, 2007.
- Julius et al.
- Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
- J Clin Apher. 22:215-23, 2007.
- Mosges et al.
- Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial.
- Eur Arch Otorhinolaryngol. 266:943-53, 2009.
- Koss et al.
- Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.
- Graefes Arch Clin Exp Ophthalmol. 247:1297-306, 2009.
- Kaneko et al.
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C.
- Hepatol Res. 40:1072-1081, 2010.
- Fernández-Fuertes et al.
- Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
- Ther Apher Dial. 14:484-5, 2010.
- Liu et al.
- Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
- J Clin Apher. 26:174-80, 2011.
- Koss et al.
- Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.
- Graefes Arch Clin Exp Ophthalmol. 247:1297-306, 2009.
- Takenaka Y.
- Bilirubin adsorbent column for plasma perfusion.
- Ther Apher. 2:129-33, 1998.
- Takenaka Y.
- Bilirubin adsorbent column for plasma perfusion.
- Ther Apher. 2:129-33, 1998.
- Senf et al.
- Bilirubin-adsorption in 23 critically ill patients with liver failure.
- Int J Artif Organs. 27:717-22, 2004.
- Adani et al.
- Selective bilirubin removal by plasma treatment with Plasorba BR-350 for early cholestatic graft dysfunction.
- Transplant Proc. 39:1904-6, 2007.
- Hirata et al.
- Immusorba TR and PH.
- Ther Apher Dial. 7:85-90, 2003.
- Yoshida et al.
- Immusorba TR and Immusorba PH: Basics of design and features of functions.
- Ther Apher. 4:127-34, 2000.
- Ota et al.
- Neutrophil activation in immunoadsorption.
- Ther Apher. 4:229-34, 2000.
- Luftl et al.
- Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber.
- Br J Dermatol. 149:598-605, 2003.
- Beige et al.
- Immunoadsorption with tryptophan adsorbers for successful treatment of late steroid-refractory recurrent focal glomerulosclerosis.
- Am J Transplant. 3:1459, 2003.
- Okamiya et al.
- Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barre syndrome.
- Ther Apher Dial. 8:248-53, 2004.
- Yoshida et al.
- Immusorba TR and IImmusorba PH: Basics of design and features of functions.
- Ther Apher. 4:127-34, 2000.
- Haupt et al.
- Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barré syndrome.
- Ther Apher. 4:198-200, 2000.
- Ota et al.
- Neutrophil activation in immunoadsorption.
- Ther Apher. 4:229-34, 2000.
- Yang et al.
- Plasma adsorption in critical care.
- Ther Apher. 6:184-8, 2002.
- Hirata et al.
- Immusorba TR and PH.
- Ther Apher Dial. 7:85-90, 2003.
- Beige et al.
- Immunoadsorption with tryptophan adsorbers for successful treatment of late steroid-refractory recurrent focal glomerulosclerosis.
- Am J Transplant. 3:1459, 2003.
- Splendiani et al.
- Plasmaperfusion on triptophan columns can improve the clinical outcome of patients affected with myasthenia gravis.
- Artif Cells Blood Substit Immobil Biotechnol. 31:69-79, 2003.
- Luftl et al.
- Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber.
- Br J Dermatol. 149:598-605, 2003.
- Okamiya et al.
- Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barre syndrome.
- Ther Apher Dial. 8:248-53, 2004.
- Seta et al.
- Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
- Clin Neurol Neurosurg. 107:491-6, 2005.
- Arakawa et al.
- Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.
- Brain Dev. 27:431-3, 2005.
- Wagner et al.
- [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
- Dtsch Med Wochenschr. 133:2377-82, 2008. German
- Galldiks et al.
- Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment.
- Eur Neurol. 66:183-9, 2011.
- Trebst et al.
- Immunoadsorption Therapy for Steroid-Unresponsive Relapses in Patients with Multiple Sclerosis.
- Blood Purif. 33:1-6, 2011.
- Yoshida et al.
- Immusorba TR and Immusorba PH: Basics of design and features of functions.
- Ther Apher. 4:127-34, 2000.
- Yang et al.
- Plasma adsorption in critical care.
- Ther Apher. 6:184-8, 2002.
- Hirata et al.
- Immusorba TR and PH.
- Ther Apher Dial. 7:85-90, 2003.
- Sugimoto et al.
- Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis.
- Ther Apher Dial. 10:187-92, 2006.
- Yamaji et al.
- Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
- Ther Apher Dial. 12:298-305, 2008.
- Loo et al.
- Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis.
- Transfus Apher Sci. 43:335-40, 2010.
Please feel free to send us any questions you may have about our products and support.





